Identification of the missing pluripotency mediator downstream of leukaemia inhibitory factor.
about
The Androgen Receptor Bridges Stem Cell-Associated Signaling Nodes in Prostate Stem CellsPluripotency Factors on Their Lineage MoveEx uno plures: molecular designs for embryonic pluripotencySignaling pathways in induced naïve pluripotencyThe ability of inner-cell-mass cells to self-renew as embryonic stem cells is acquired following epiblast specificationMolecular basis of embryonic stem cell self-renewal: from signaling pathways to pluripotency networkRetrotransposons shape species-specific embryonic stem cell gene expressionGenetic exploration of the exit from self-renewal using haploid embryonic stem cellsCharacterization of the finch embryo supports evolutionary conservation of the naive stage of development in amniotesTracking the embryonic stem cell transition from ground state pluripotency.Primate embryogenesis predicts the hallmarks of human naïve pluripotency.Transcriptional control of spermatogonial maintenance and differentiationRole of tumor suppressor genes in the cancer-associated reprogramming of human induced pluripotent stem cells.Otx2 and Oct4 drive early enhancer activation during embryonic stem cell transition from naive pluripotency.Transcription factor TFCP2L1 patterns cells in the mouse kidney collecting ducts.Chromatin module inference on cellular trajectories identifies key transition points and poised epigenetic states in diverse developmental processes.Resetting transcription factor control circuitry toward ground-state pluripotency in human.NANOG amplifies STAT3 activation and they synergistically induce the naive pluripotent program.Collaborative rewiring of the pluripotency network by chromatin and signalling modulating pathwaysProspects for clinical use of reprogrammed cells for autologous treatment of macular degeneration.Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to naive-like pluripotency.How are pluripotent cells captured in culture?Pluripotency and Epigenetic Factors in Mouse Embryonic Stem Cell Fate RegulationCell-Specific Cre Strains For Genetic Manipulation in Salivary GlandsRequirement of Leukemia Inhibitory Factor or Epidermal Growth Factor for Pre-Implantation Embryogenesis via JAK/STAT3 Signaling PathwaysLineage-Specific Profiling Delineates the Emergence and Progression of Naive Pluripotency in Mammalian EmbryogenesisEstablishment of leukemia inhibitory factor (LIF)-independent iPS cells with potentiated Oct4Myc Depletion Induces a Pluripotent Dormant State Mimicking DiapauseStat3 promotes mitochondrial transcription and oxidative respiration during maintenance and induction of naive pluripotency.Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 inductionNaive Pluripotent Stem Cells Derived Directly from Isolated Cells of the Human Inner Cell MassTowards Functional Annotation of the Preimplantation Transcriptome: An RNAi Screen in Mammalian EmbryosDo all roads lead to Oct4? the emerging concepts of induced pluripotency.Protein kinases and associated pathways in pluripotent state and lineage differentiation.Mapping the route from naive pluripotency to lineage specification.Pluripotency and the endogenous retrovirus HERVH: Conflict or serendipity?LIF signal in mouse embryonic stem cells.Modeling heterogeneity in the pluripotent state: A promising strategy for improving the efficiency and fidelity of stem cell differentiation.Glycans define the stemness of naïve and primed pluripotent stem cells.Formative pluripotency: the executive phase in a developmental continuum
P2860
Q26765892-6297233D-0806-4B78-92ED-876897AD31A9Q26771912-F86EB83A-6078-48EF-8254-35154A7CCD5CQ26860750-CC180B86-CA36-4846-88D5-153AB05E36A0Q27023411-D6FA7A9F-72A9-4E99-864A-241D3D91AFC5Q27313398-91196934-7943-437C-B828-B92A1D08A6D8Q28084007-E2BFA2C2-1866-479D-AA04-DBA3681A2D70Q28085502-50B45B38-B83E-459C-A7C1-72C0E440AA77Q28587174-80D9725E-6830-4B55-8AF4-0255D1C03B52Q28611189-CA3B8023-4C6C-433E-A92D-3A70944A2AEEQ33588332-FF8A0F4F-872B-439F-ADEA-471C7D7BE8E2Q33682621-85C345A9-B4F7-4597-B2BF-0D93C24DFE11Q33707028-527CF356-79C4-4EE7-B73A-A8349770DAC6Q33752469-2169B7D3-4A35-4A4B-9431-FAD05A7FBE1FQ33818368-2FA696B1-E565-499B-B5E9-5864D947D1B4Q33835043-1BBE7E61-A486-46FB-BE91-EC252ABBACD4Q33865195-928CD53B-8856-4012-AB9F-26E9BE6DA616Q34173263-0865C7E7-84A0-4041-BB36-444BBAF32494Q34399958-86015100-F508-46BE-AE98-1E262ED38EABQ35139931-8ADD5E6F-CC6A-4B79-8503-AEDEF3FD4ED7Q35608700-32584B1D-7501-4144-B991-8917AFBDF115Q35775443-E077A1FE-5A02-4109-9234-980C59F100AFQ35812686-3F0D1D83-B77B-4BCD-82E0-A6EE630AEC8FQ35868403-3E909929-C3B0-41CB-A565-124850E96250Q35890157-161C29D8-218E-4D09-BA2F-7045259138E8Q35994816-89010300-FBAF-4902-8FA3-F43AC711EA97Q36275655-AAA11291-F484-4EA6-8FA6-83BC929E35BEQ36421360-F87D9693-CEC8-4031-86E8-AB99DAF7FA78Q36577855-75B4BF53-EE17-4E53-9EEC-F2CE73D7CAC6Q36712631-95F773C5-0815-415E-940B-9B3EEA78AF8BQ36782261-B0434531-D7B1-401C-84BB-E682CCB0AA1EQ36805009-7BB10923-268E-4325-B20C-8BC0513FFA26Q37424848-EF69E522-6420-49E4-B99E-5F6C63E99984Q37686970-FC130663-AEEB-464A-9156-A641EC0DFFB8Q38226659-DD6422B4-BC5D-4249-9016-8973F24B0705Q38263165-C8E66978-A902-4B3B-8D29-6F2B386528ABQ38688205-B0AAAEAB-2C60-470E-B316-FBFDA5CBF08CQ38820725-EA5E98FC-EAE4-4A05-AFCB-95B906A54AD9Q38870181-CCAA2986-5185-43B9-8275-CEB94EF96507Q38994671-0818885D-8174-4ADD-9266-4233A8DFED9DQ39112403-382F19FE-EF08-4340-A26F-5D095BA3DAAC
P2860
Identification of the missing pluripotency mediator downstream of leukaemia inhibitory factor.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identification of the missing ...... f leukaemia inhibitory factor.
@en
Identification of the missing ...... f leukaemia inhibitory factor.
@nl
type
label
Identification of the missing ...... f leukaemia inhibitory factor.
@en
Identification of the missing ...... f leukaemia inhibitory factor.
@nl
prefLabel
Identification of the missing ...... f leukaemia inhibitory factor.
@en
Identification of the missing ...... f leukaemia inhibitory factor.
@nl
P2860
P356
P1433
P1476
Identification of the missing ...... of leukaemia inhibitory factor
@en
P2093
Graziano Martello
P2860
P304
P356
10.1038/EMBOJ.2013.177
P407
P577
2013-08-13T00:00:00Z